Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 438, pseudogene (RNU6-438P) is a pseudogene—a genomic DNA sequence similar to functional genes but generally non-functional due to accumulated mutations[1][3]. Pseudogenes do not encode functional proteins, but some are transcribed into non-coding RNAs that may have regulatory roles at the RNA level (e.g., as antisense transcripts or sources of small RNAs)[4][5]. There is no evidence that RNU6-438P is transcribed or has regulatory, diagnostic, or therapeutic significance. It is not considered a druggable target, nor a receptor, enzyme, or classical molecular mediator in disease. RNU6-438P is a non-functional pseudogene, not a drug target, with no established biological, pathological, or therapeutic relevance[1][3]. Its only role, like that of many pseudogenes, is as an element of genomic architecture, with potential but unproven contributions to RNA-level regulatory networks in rare instances.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 438, pseudogene (RNU6-438P).